Tat-CIRP TFA

Tat-CIRP is a peptide inhibitor that disrupts the MD-2/CIRP interaction, a key pathway in sterile inflammation. It has demonstrated efficacy in reducing cerebral infarct volume and improving functional outcomes in both rodent and non-human primate models of ischemic stroke, supporting its use in neuroinflammation and stroke research.